Tuesday, November 26, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
psychedelic stock review
Psychedelic News

Advances in Psychedelics can Change Investors’ Minds

Editor / Curator -
Psychedelic News

That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested...

Editor / Curator -
Internet News

Smile for the camera: the dark side of China’s emotion-recognition tech...

Editor / Curator -
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Most Every Morning.

Editor / Curator -
Provention
Diabetes

Teplizumab: Can We Delay the Onset of Type 1? (DiaTribe)

Editor / Curator -
AI Artificial Intelligence

Adding Amplitech Group (AMPG) $5.04 to Watch List.

Editor / Curator -
Hea;thLynked, Biotech Stock Review
Telehealth

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Aphex BioCleanse (SNST) Making Serious Headlines.

Editor / Curator -
Drones

Draganfly (DFLYF) to Deploy Aerial Sanitation Drones Over NASCAR Event.

Editor / Curator -
Danny Ritman
AI Artificial Intelligence

GBT Technologies (GTCH) Aims to Power Wearable GPS Tracker for Seniors.

Editor / Curator -
1...444546...93Page 45 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.